Several studies have demonstrated the important anti-cancer role of FKBPL and its therapeutic peptide derivatives, AD-01 (a preclinical peptide candidate) and ALM201 (clinical peptide candidate), which target angiogenesis via CD4414,15. The gene discussed is FKBPL; the disease is cancer.